25874995|t|Tabersonine inhibits amyloid fibril formation and cytotoxicity of Abeta(1-42).
25874995|a|The misfolding and aggregation of amyloid beta (Abeta) peptides into amyloid fibrils are key events in the amyloid cascade hypothesis for the etiology of Alzheimer's disease (AD). Using thioflavin-T (ThT) fluorescence assay, atomic force microscopy, circular dichroism, size exclusion chromatography, surface plasmon resonance (SPR), and cytotoxicity tests, we demonstrate that tabersonine, an ingredient extracted from the bean of Voacanga africana, disrupts Abeta(1-42) aggregation and ameliorates Abeta aggregate-induced cytotoxicity. A small amount of tabersonine (e.g., 10 muM) can effectively inhibit the formation of Abeta(1-42) (e.g., 80 muM) fibrils or convert mature fibrils into largely innocuous amorphous aggregates. SPR results indicate that tabersonine binds to Abeta(1-42) oligomers in a dose-dependent way. Molecular dynamics (MD) simulations further confirm that tabersonine can bind to oligomers such as the pentamer of Abeta(1-42). Tabersonine preferentially interact with the beta-sheet grooves of Abeta(1-42) containing aromatic and hydrophobic residues. The various binding sites and modes explain the diverse inhibitory effects of tabersonine on Abeta aggregation. Given that tabersonine is a natural product and a precursor for vincristine used in cancer chemotherapy, the biocompatibility and small size essential for permeating the blood-brain barrier make it a potential therapeutic drug candidate for treating AD. 
25874995	0	11	Tabersonine	Chemical	MESH:C009373
25874995	21	28	amyloid	Disease	MESH:C000718787
25874995	50	62	cytotoxicity	Disease	MESH:D064420
25874995	113	125	amyloid beta	Gene	351
25874995	127	132	Abeta	Gene	351
25874995	148	155	amyloid	Disease	MESH:C000718787
25874995	186	193	amyloid	Disease	MESH:C000718787
25874995	233	252	Alzheimer's disease	Disease	MESH:D000544
25874995	254	256	AD	Disease	MESH:D000544
25874995	265	277	thioflavin-T	Chemical	MESH:C009462
25874995	279	282	ThT	Chemical	MESH:C009462
25874995	417	429	cytotoxicity	Disease	MESH:D064420
25874995	457	468	tabersonine	Chemical	MESH:C009373
25874995	511	528	Voacanga africana	Species	141630
25874995	579	584	Abeta	Gene	351
25874995	603	615	cytotoxicity	Disease	MESH:D064420
25874995	635	646	tabersonine	Chemical	MESH:C009373
25874995	835	846	tabersonine	Chemical	MESH:C009373
25874995	960	971	tabersonine	Chemical	MESH:C009373
25874995	1031	1042	Tabersonine	Chemical	MESH:C009373
25874995	1234	1245	tabersonine	Chemical	MESH:C009373
25874995	1249	1254	Abeta	Gene	351
25874995	1279	1290	tabersonine	Chemical	MESH:C009373
25874995	1332	1343	vincristine	Chemical	MESH:D014750
25874995	1352	1358	cancer	Disease	MESH:D009369
25874995	1518	1520	AD	Disease	MESH:D000544
25874995	Negative_Correlation	MESH:C009373	MESH:C000718787
25874995	Association	MESH:C000718787	351
25874995	Positive_Correlation	MESH:D064420	351
25874995	Negative_Correlation	MESH:C009373	351
25874995	Negative_Correlation	MESH:D014750	MESH:D009369
25874995	Negative_Correlation	MESH:C009373	MESH:D000544
25874995	Negative_Correlation	MESH:C009373	MESH:D064420
25874995	Association	MESH:D000544	351
25874995	Negative_Correlation	MESH:C009373	MESH:D009369

